Should you buy last week’s winners Lonmin plc (+15%), Bovis Homes Group plc (+12%) and Whitbread plc (+9%)?

Royston Wild considers whether Lonmin plc (LON: LMI), Bovis Homes Group plc (LON: BVS) and Whitbread plc (LON: WTB) can keep on charging.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am considering the investment case for three recent Footsie risers.

Platinum bomb

Precious metals digger Lonmin (LSE: LMI) saw its shares surge again last week, with bubbly market appetite coming despite another plunge in platinum prices.

The dual-role metal — it’s used both as an investment metal as well as a key component in various industries and the jewellery market — slipped back towards the critical $1,000 per ounce marker as the US dollar strengthened.

Recent Federal Reserve comments suggesting that interest rates could be back on the agenda has propelled the greenback higher, and I believe additional strength may materialise in the months ahead, applying fresh pressure to the metal. And of course fears over the health of the Chinese economy may cause further problems for platinum values.

Lonmin rose last week after announcing strong progress in its cost-cutting mission, a programme that helped it record a $21m pre-tax loss during October-March. This marked a vast improvement from the $118m loss clocked up in the same period last year.

However, the number crunchers expect Lonmin to remain in the red in 2016, with losses of 9 US cents per share currently pencilled in.

And with the digger still facing a murky revenues outlook, I reckon investors hoping for a bottom-line bounceback may end sorely disappointed. I believe Lonmin’s surging share price provides a terrific selling opportunity.

Building beauty

I am far more optimistic concerning the profits prospects of Bovis Homes (LSE: BVS), however.

The housebuilder has gained significant traction since its AGM earlier this month, its share price taking in four-and-a-half-month peaks just shy of £10 in the process. And this comes as little surprise, at least in my opinion. Bovis announced at the meeting that

housing market conditions remain positive with strong demand from home buyers who are benefitting from good access to mortgage finance.”

With construction activity still failing to meet this brilliant demand, the City expects Bovis to keep chalking up stellar earnings rises — indeed, a 16% earnings rise is projected for this year alone, resulting in a mega-low P/E rating of 8.9 times.

And with the business boasting a market-mashing yield of 4.6% for 2016, I reckon there is plenty of room for Bovis’s stock value to keep sprinting.

Coffee colossus

Bed and beverage play Whitbread (LSE: WTB) also touched levels not seen since the start of 2016 last week, keeping its spritely performance in May going.

Investors are becoming bullish sales continue to surge across the group. Whitbread saw revenues canter 12% higher in the 12 months to February 2016, with sales at its Costa coffee chain rising 15.9% and takings at Premier Inn increasing 12.9%. And I expect revenues to keep rising as Whitbread expands these brands across the globe.

This view is shared by the abacus bashers, and an earnings expansion of 4% is pencilled in for 2017 alone. A consequent P/E rating of 17.3 times for may be slightly toppy on paper, but I believe this represents fair value when you factor in the electric growth potential thrown up by Whitbread’s ambitious expansion programme.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »